APIs

Lenalidomide

Lenalidomide is indicated for the treatment of multiple myeloma in combination with dexamethasone. It is also indicated for the treatment of patients with transfusion-dependent anemia due to low- or intermediate- risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities....
Products Inquiry

Description

Product Name:   Lenalidomide
Chemical Name:   3­-(4-amino-1-oxo 1,3-dihydro-2H-isoindol-2-yl) piperidine-2,6-dione
Cas No.:   191732-72-6
Molecular Formula:   C13H13N3O3
Molecular Weight:   259.26
Purity:   ≥99.0%
Quality Standard:   Enterprise standard
Indications:   Multiple myeloma, Myelodysplastic syndromes